Some Pediatric Patients With Wilms' Tumor Can Avoid Doxorubicin
the ONA take:
According to a new study published in the journal The Lancet, researchers have found that children with Wilm's tumor who are at low risk for relapse can be given less intensive treatment by omitting doxorubicin from the treatment regimen.
For the 10-year trial, researchers followed 583 pediatric patients with stage II or III Wilm's tumor who were at intermediate risk for disease relapse. Results demonstrated that 96.5% of patients whose treatment regimen contained doxorubicin survived for 5 or more years versus 95.8% of those who did not receive the cardiotoxic drug. Researchers found that those who did not receive doxorubicin and relapsed could be successfully re-treated.
"Thanks to the results of this trial fewer children with this disease will have to have treatment that could cause them lifelong side effects without much benefit," lead author Professor Kathy Pritchard-Jones, a researcher at the Institute of Child Health, University College London and consultant oncologist at Great Ormond Street Hospital in London said.
Children with Wilm's tumor who are at low risk for relapse can be given less intensive treatment by omitting doxorubicin from the treatment regimen.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- Adding Pertuzumab to Adjuvant Therapy Is Beneficial for Some Women with Early Breast Cancer
- Clinical Trials May Benefit Oncology Patients
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Breast Cancer Diagnosis and Nurse Navigation Survey
- Breast Cancer Overdiagnosis Also a Result of Screening Mammography Programs
- Use of Aspirin, NSAIDs Correlates with Improved Overall Survival in Colorectal Cancer
- Cancer Risk Not Increased by Childhood Exposure to Diagnostic Radiation
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|